Clinical Trials Logo

Varicose Veins clinical trials

View clinical trials related to Varicose Veins.

Filter by:

NCT ID: NCT04210297 Completed - Clinical trials for Esophageal and Gastric Varices

Development and Validation of an Noninvasive Model for Predicting High Risk Esophageal Varices in Cirrhosis

Start date: January 1, 2018
Phase:
Study type: Observational

The aim of the study is to develop and validate a new noninvasive method based on routine examination during clinical practice for predicting high risk esophageal varices in cirrhosis.

NCT ID: NCT04148950 Completed - Clinical trials for Varicose Veins of Lower Limb

Effects of Kinesio Taping Method on Functional Capacity and Quality of Life in Patients With Chronic Venous Disease

Start date: May 2013
Phase: N/A
Study type: Interventional

The purpose of this randomised and controlled study is to investigate the effects of Kinesio Taping method and compression stockings, combined with exercise therapy, on pain, edema, functional capacity and quality of life in patients with chronic venous disease. Therefore, the study compares effectiveness of these two methods for chronic venous disease.

NCT ID: NCT04036734 Completed - Varicose Veins Clinical Trials

Longitudinal or Transverse Orientation of Ultrasound Probe in Minimally Invasive Venous Surgery.

Start date: July 24, 2019
Phase: N/A
Study type: Interventional

Longitudinal ultrasound orientation during central venous cannulation has been suggested by a number of radomised studies to offer superior cannulation rates. This technique may offer a simple, safe and cost-neutral step to improve cannulation rates in the widely performed minimally invasive endovenous intervention.

NCT ID: NCT04006184 Completed - Varicose Veins Clinical Trials

Retrospective Review of Saphenous Vein Incompetence: Venaseal Versus Endovenous Thermal Ablation

VALUE
Start date: June 14, 2019
Phase:
Study type: Observational

This study is a retrospective, chart review of treatment of patients with symptomatic varicose veins. Treated limbs must have the Great Saphenous Vein and/or Small Saphenous Vein treated with either cyanoacrylate closure (VenaSeal) or Endothermal Ablation (either Radiofrequency Ablation or Endovenous Laser Ablation).

NCT ID: NCT03921788 Completed - Pelvic Pain Clinical Trials

Neuropeptides and Venous Pelvic Pain

NVPP
Start date: April 1, 2019
Phase:
Study type: Observational

Mechanisms of the development of pain in chronic venous diseases (CVD), including pelvic congestion syndrome (PCS), are studied incompletely. The existing hypotheses of the occurrence of venous pelvic pain (VVP) do not allow to answer the question why some patients have no pain syndrome while others have very pronounced pain despite the same morphofunctional changes in the pelvic veins? The investigators are planning to carry out a study aimed at studying the content of calcitonin gene-related peptide (CGRP) and substance P (SP) in the serum of patients with pelvic veins and pelvic pain, and to study the relationship between the values of CGRP and SP in these patients.

NCT ID: NCT03893201 Completed - Varicose Veins Clinical Trials

A Singapore Venaseal Real World Post-Market Evaluation Study

ASVS
Start date: April 11, 2018
Phase:
Study type: Observational

The study aims to assess the efficacy of VenaSealâ„¢ Closure System (VCS) for the treatment of lower extremity superficial truncal veins in a real-world clinical setting, in a multi-racial Asian population in Singapore.

NCT ID: NCT03856814 Completed - Varicose Veins Clinical Trials

Market Penetration of Laser Therapy in Venous Surgery: Ziekenhuis Oost-Limburg - Ziekenhuis Maas en Kempen Center Experience

Start date: March 15, 2019
Phase:
Study type: Observational [Patient Registry]

The goal of this registry is to evaluate the indication for EndoVenous Laser Ablation (EVLA) therapy. Can this be enhanced? What are the reasons for not using the laser? Therefore, this study aims to define clear indications for EVLA by registering the incentives of the participating investigators to use the laser instead of conventional corrective surgery for the treatment of varicose veins, at baseline and post-operative. Additionally, the efficacy and safety of the different varicose vein treatments will be evaluated by registering procedural characteristics, anatomic outcome (duplex ultrasound), quality of life (AVVQ) and postoperative pain (VAS).

NCT ID: NCT03850496 Completed - Varicose Veins Clinical Trials

DESIVI: Dosing of Electrical Stimulation in Venous Insufficiency

DESIVI
Start date: November 1, 2015
Phase: N/A
Study type: Interventional

This study is designed to describe the difference in varicose vein outcomes found from using a neuromuscular electrical stimulation device for different amounts of time - Group A (control - no device), Group B (device for 30 mins per day) and Group C (device for 60 mins per day). The groups are assessed after 6 weeks of intervention.

NCT ID: NCT03810677 Completed - Varicose Veins Clinical Trials

Treatment of Varicose Veins With the ELVeS® Radial® 2ring Slim Fiber. Are There Limitations?

Start date: April 15, 2019
Phase:
Study type: Observational [Patient Registry]

This study aims to prove that the ELVeS® Radial® 2ring slim fiber is safe and effective in endovenous laser ablation (EVLA) of varicose veins, with a reliable durability by evaluating procedural details/outcomes, clinical success, anatomic success, pain, post-operative adverse events and re-interventions.

NCT ID: NCT03748563 Completed - Liver Cirrhosis Clinical Trials

Accuracy of Magnetically Maneuvered Capsule Endoscopy for Detection of EGV in Patients With Cirrhosis

Start date: January 7, 2021
Phase: N/A
Study type: Interventional

This is a diagnostic accuracy study. Eligible individuals will be enrolled and asked to undergo ds-MCE and EGD examinations. EGD is the reference standard against which ds-MCE is compared, and it will be performed within 48 hours after ds-MCE examination. The primary outcome is the sensitivity and specificity of ds-MCE in identifying the presence of esophagogastric (EGV) in patients with cirrhosis, using detection by EGD as the reference. The diagnostic accuracy of ds-MCE in detection of high-risk EV, high-risk EGV, EV, large EV, red signs of EV, GV, cardiofundal GV and PHG compared with the EGD will also be assessed. The incidence of PHE in small bowel under ds-MCE, the examination time of ds-MCE and EGD procedures, patient satisfaction assessment and safety evaluation will also be evaluated.